Category Archives: Cancer Researchers

Under Clay Siegall’s leadership, Seattle Genetics sees wide diversification of revenue

Every Finance 101 course will teach you that diversification is key to risk management, no matter how large or small the portfolio of investments. However, for some types of companies, diversification is a difficult thing to achieve. This is particularly … Continue reading

Posted in Cancer Researchers | Leave a comment